D-FI

Welcome to the Brand page for “D-FI”, which is offered here for Gene therapy products, pharmaceutical preparations, and injectable biologic preparations containing genetically modified materials for treatment of dystrophic epidermolysis bullosa; pharmaceutical preparations and therapeutic preparations for skin diseases, connective tissue diseases, arthritis and autoimmune diseases;.

Its status is currently believed to be active. Its class is unavailable. “D-FI” is believed to be currently owned by “Castle Creek Biosciences, LLC”.